| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 7.414 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 7.414 | 0 | 15.233 |
| Total Expenses - EUR | - | - | - | - | - | - | 3.715 | 4.754 | -170 | 15.169 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -3.715 | 2.660 | 170 | 64 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -3.715 | 2.437 | 128 | 53 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Endovelicus Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 15.493 | 16.389 | 16.233 | 16.415 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 14.919 | 14.965 | 14.920 | 14.851 |
| Cash | - | - | - | - | - | - | 574 | 1.424 | 1.313 | 1.564 |
| Shareholders Funds | - | - | - | - | - | - | -3.675 | -1.249 | -1.117 | -1.057 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 19.168 | 17.638 | 17.349 | 17.472 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Endovelicus Med S.r.l.